when will there be generic glp 1 Article » ProAct Navigating the GLP-1 Generic Drug

The surge in litigation underscores the rising awareness of the potential risks tied to Ozempic and the growing number of individuals taking legal action

While GLP-1 RAs reduce food intake by dampening hyperactive reward responses to palatable cues, they appear to preserve general reward sensitivity, differentiating them from medications that blunt dopaminergic tone nonspecifically [81,92]

E.RupprechtL

Throughout this process, we observed that both cases tolerated the protocol without any complaints or complications

My question: given my MS stability but significant metabolic risk factors (obesity, pre-diabetes, cholesterol, thyroid), do you think a GLP-1 agonist (such as tirzepatide or semaglutide) would be a reasonable option for me

Regulatory concerns are significant